{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:30:24Z","timestamp":1793356224396,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.anai.2026.06.012","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:38:12Z","timestamp":1782625092000},"page":"641-649.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome"],"prefix":"10.1016","volume":"137","author":[{"given":"Anna","family":"Nowak-Wegrzyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Slatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Rance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-9372","authenticated-orcid":false,"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2026.06.012_bib0001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.anai.2026.06.012_bib0002","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/all.12272","article-title":"The epidemiology of anaphylaxis in Europe: a systematic review","volume":"68","author":"Panesar","year":"2013","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2026.06.012_bib0003","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2019.11.027","article-title":"Global trends in anaphylaxis epidemiology and clinical implications","volume":"8","author":"Turner","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2026.06.012_bib0004","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/all.13732","article-title":"The global incidence and prevalence of anaphylaxis in children in the general population: a systematic review","volume":"74","author":"Wang","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2026.06.012_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005750","article-title":"True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.anai.2026.06.012_bib0006","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2025.01.021","article-title":"Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report-a GA2LEN project","volume":"156","author":"Dribin","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.06.012_bib0007","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2026.06.012_bib0008","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/pharmaceutics16060811","article-title":"Development of neffy, an epinephrine Nasal Spray, for Severe Allergic Reactions","volume":"16","author":"Ellis","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.anai.2026.06.012_bib0009","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaip.2025.12.022","article-title":"Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community","volume":"14","author":"Dribin","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.06.012_bib0010","unstructured":"Food and Drug Administration. FDA alerts patients and health care professionals of EpiPen Auto-Injector errors related to device malfunctions and user administration. Accessed March 31, 2025. Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-alerts-patients-and-health-care-professionals-epipen-auto-injector-errors-related-device"},{"issue":"2","key":"10.1016\/j.anai.2026.06.012_bib0011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2025.11.008","article-title":"Epinephrine and emergency medical services activation recommendations during acute allergic reactions in community settings: international consensus report","volume":"157","author":"Dribin","year":"2026","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.06.012_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-7022-2-3","article-title":"What factors affect the carriage of epinephrine auto-injectors by teenagers?","volume":"2","author":"Macadam","year":"2012","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.06.012_bib0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/03007995.2025.2459784","article-title":"US general population food allergy treatment preferences: a discrete choice experiment","volume":"41","author":"Mickle","year":"2025","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"10.1016\/j.anai.2026.06.012_bib0014","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jaip.2019.03.021","article-title":"Patient carrying time, confidence, and training with epinephrine autoinjectors: the RACE survey","volume":"7","author":"Portnoy","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.06.012_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.anai.2018.06.010","article-title":"Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults","volume":"121","author":"Warren","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.06.012_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.06.012_bib0017","unstructured":"Aquestive Therapeutics. Collaborations and co-development (PharmFilm). Accessed March 31, 2025. Available at:https:\/\/aquestive.com\/collaborations\/"},{"key":"10.1016\/j.anai.2026.06.012_bib0018","unstructured":"Aquestive Therapeutics. Licensed commercial medicines (PharmFilm). Accessed March 31, 2025. Available at: https:\/\/aquestive.com\/medicines\/licensed-commercial-medicines-2\/"},{"issue":"5","key":"10.1016\/j.anai.2026.06.012_bib0019","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.anai.2025.01.006","article-title":"Integrated phase I pharmacokinetics and pharmacodynamics of epinephrine administered through sublingual film, autoinjector, or manual injection","volume":"134","author":"Kraus","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2026.06.012_bib0020","unstructured":"Aquestive Therapeutics. SUBOXONE\u00ae (buprenorphine and naloxone) prescribing information. Accessed April 15, 2026. Available at: https:\/\/www.suboxone.com\/."},{"key":"10.1016\/j.anai.2026.06.012_bib0021","series-title":"ZUPLENZ\u00ae (Ondansetron Oral Soluble Film, USPI) highlights of prescribing information","year":"2021"},{"key":"10.1016\/j.anai.2026.06.012_bib0022","series-title":"Paper presented at: Eastern Allergy Conference","article-title":"The physicochemical properties of AnaphylmTM under extreme temperatures and real-world conditions","author":"Confer","year":"2025"},{"issue":"6","key":"10.1016\/j.anai.2026.06.012_bib0023","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jaip.2020.02.010","article-title":"Food allergy from infancy through adulthood","volume":"8","author":"Sicherer","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.06.012_bib0024","series-title":"Core Patient-Reported Outcomes in Cancer Clinical Trials Guidance for Industry","year":"2024"},{"key":"10.1016\/j.anai.2026.06.012_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/PROM.S178344","article-title":"Truthfulness in patient-reported outcomes: factors affecting patients\u2019 responses and impact on data quality","volume":"10","author":"Chang","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.anai.2026.06.012_bib0026","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41687-018-0056-3","article-title":"Literature review to assemble the evidence for response scales used in patient-reported outcome measures","volume":"2","author":"Gries","year":"2017","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"10.1016\/j.anai.2026.06.012_bib0027","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI109840","article-title":"Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man","volume":"66","author":"Clutter","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anai.2026.06.012_bib0028","series-title":"Paper presented at: Eastern Allergy Conference","article-title":"Epinephrine delivered via sublingual film (AnaphylmTM) elicits rapid and consistent pharmacokinetic and pharmacodynamic responses","author":"Kraus","year":"2025"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:30:20Z","timestamp":1793352620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626002735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1081120626002735"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.06.012","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}